A single arm phase Ib/II trial of first-line pembrolizumab, trastuzumab and chemotherapy for advanced HER2-positive gastric cancer.
Lee CK, Rha SY, Kim HS, Jung M, Kang B, Che J, Kwon WS, Park S, Bae WK, Koo DH, Shin SJ, Kim H, Jeung HC, Zang DY, Lee SK, Nam CM, Chung HC.
Lee CK, et al. Among authors: jeung hc.
Nat Commun. 2022 Oct 12;13(1):6002. doi: 10.1038/s41467-022-33267-z.
Nat Commun. 2022.
PMID: 36224176
Free PMC article.
Clinical Trial.